» Articles » PMID: 36819098

Current Insights into the Functional Roles of Ferroptosis in Musculoskeletal Diseases and Therapeutic Implications

Overview
Specialty Cell Biology
Date 2023 Feb 23
PMID 36819098
Authors
Affiliations
Soon will be listed here.
Abstract

Ferroptosis is a novel type of cell death associated with iron accumulation and excessive lipid peroxidation. Elucidating the underlying molecular mechanisms of ferroptosis is intensively related to the development and treatment of multiple diseases, including musculoskeletal disorders. Moreover, and studies have shown the importance of oxidative stress in musculoskeletal conditions such as osteoporosis, osteoarthritis, rheumatoid arthritis, and osteosarcoma. Ferroptosis-derived clinical management of musculoskeletal diseases offers tremendous and attractive opportunities. Notably, ferroptosis agonists have been proven to enhance the sensitivity of osteosarcoma cells to conventional therapeutic strategies. In this review, we have mainly focused on the implications of ferroptosis regulation in the pathophysiology and therapeutic response of musculoskeletal disorders. Understanding roles of ferroptosis for controlling musculoskeletal diseases might provide directions for ferroptosis-driven therapies, which could be promising for the development of novel therapeutic strategies.

Citing Articles

CUR-PDT induces ferroptosis of RA-FLS via the Nrf2/xCT/GPX4 pathway to inhibit proliferation in rheumatoid arthritis.

Sun L, Niu Y, Liao B, Liu L, Peng Y, Li K Inflamm Res. 2025; 74(1):53.

PMID: 40085199 DOI: 10.1007/s00011-025-02019-2.


Autophagy and Programmed Cell Death Modalities Interplay in HIV Pathogenesis.

Lamsira H, Sabatini A, Ciolfi S, Ciccosanti F, Sacchi A, Piacentini M Cells. 2025; 14(5).

PMID: 40072080 PMC: 11899401. DOI: 10.3390/cells14050351.


Thyroid-associated ophthalmopathy and ferroptosis: a review of pathological mechanisms and therapeutic strategies.

Ma C, Li H, Lu S, Li X Front Immunol. 2024; 15:1475923.

PMID: 39712031 PMC: 11659143. DOI: 10.3389/fimmu.2024.1475923.


Ferroptosis in Osteoarthritis: Towards Novel Therapeutic Strategy.

Zhang Y, Li J, Liu J, Gao Y, Li K, Zhao X Cell Prolif. 2024; 58(3):e13779.

PMID: 39624950 PMC: 11882765. DOI: 10.1111/cpr.13779.


Contemporary insights and prospects on ferroptosis in rheumatoid arthritis management.

Zhao H, Dong Q, Hua H, Wu H, Ao L Front Immunol. 2024; 15:1455607.

PMID: 39381004 PMC: 11458427. DOI: 10.3389/fimmu.2024.1455607.


References
1.
Pan L, Zhang Y, Chen N, Yang L . Icariin Regulates Cellular Functions and Gene Expression of Osteoarthritis Patient-Derived Human Fibroblast-Like Synoviocytes. Int J Mol Sci. 2018; 18(12). PMC: 5751258. DOI: 10.3390/ijms18122656. View

2.
Santana-Codina N, Gikandi A, Mancias J . The Role of NCOA4-Mediated Ferritinophagy in Ferroptosis. Adv Exp Med Biol. 2021; 1301:41-57. DOI: 10.1007/978-3-030-62026-4_4. View

3.
Ursini F, Maiorino M . Lipid peroxidation and ferroptosis: The role of GSH and GPx4. Free Radic Biol Med. 2020; 152:175-185. DOI: 10.1016/j.freeradbiomed.2020.02.027. View

4.
Fuhrmann D, Mondorf A, Beifuss J, Jung M, Brune B . Hypoxia inhibits ferritinophagy, increases mitochondrial ferritin, and protects from ferroptosis. Redox Biol. 2020; 36:101670. PMC: 7452134. DOI: 10.1016/j.redox.2020.101670. View

5.
Yang S, Ryu J, Oh H, Jeon J, Kwak J, Kim J . NAMPT (visfatin), a direct target of hypoxia-inducible factor-2α, is an essential catabolic regulator of osteoarthritis. Ann Rheum Dis. 2013; 74(3):595-602. PMC: 4345811. DOI: 10.1136/annrheumdis-2013-204355. View